30
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38826 |
Vibozilimod
Vibozilimod,SCD-044 |
S1P Receptor | GPCR/G Protein |
Vibozilimod (SCD-044) 是S1P 受体-1 (S1PR1)激动剂。 | |||
T5427 |
GSK1940029
SCD inhibitor 1 |
Dehydrogenase; Stearoyl-CoA Desaturase (SCD) | Metabolism |
GSK1940029 (SCD inhibitor 1) 是酰基-辅酶A 去饱和酶 (SCD) 抑制剂。 | |||
T10525 |
SCD1 inhibitor-4
|
Dehydrogenase; Stearoyl-CoA Desaturase (SCD) | Metabolism |
SCD1 inhibitor-4 是一种具有口服活性的 stearoylCoA desaturase-1 抑制剂,可用于研究糖尿病。 | |||
T38683 |
SCD1 inhibitor-3
SCD1-IN-3,SCD1 inhibitor-3,SCD1 inhibitor 17a |
Dehydrogenase | Metabolism |
SCD1 inhibitor-3 (ML-270) 是一种高效、口服的化合物,可以抑制SCD1,且安全性极高。 SCD1 inhibitor-3 显示出在代谢疾病(包括肥胖、二型糖尿病和血脂异常,以及痤疮和癌症等各种皮肤病)方面的巨大研究潜力。 | |||
T2650 |
MK-8245
|
Dehydrogenase; Stearoyl-CoA Desaturase (SCD) | Metabolism |
MK8245 是肝靶向的硬脂酰 -CoA 去饱和酶(SCD)抑制剂,对人 SCD1 和鼠 SCD1 的IC50值分别为 1 nM 和 3 nM,具有抗糖尿病和抗血脂异常的作用。 | |||
T13356 |
XEN723
|
Dehydrogenase; Stearoyl-CoA Desaturase (SCD) | Metabolism |
XEN723 是新型的硬脂酰辅酶 A 去饱和酶的噻唑基咪唑烷酮抑制剂,能够抑制小鼠和 HepG2 细胞的活性,它们的 IC50值分别为 45 和 524 nM。 | |||
T16068 |
MF-438
|
Dehydrogenase; Stearoyl-CoA Desaturase (SCD) | Metabolism |
MF-438 是一种口服具有活力的 stearoyl-CoA desaturase 1 抑制剂,其对 rSCD1 的 EC50值为 2.3 nM。 | |||
T6412 |
CVT-12012
|
Stearoyl-CoA Desaturase (SCD) | Metabolism |
CVT-12012 是口服具有活性的硬脂酰-CoA 去饱和酶抑制剂,能够抑制大鼠微粒体和人 HEPG2 的活性,它们的IC50值分别为 38 nM,6.1 nM。 | |||
T4515 |
A939572
|
Dehydrogenase; Stearoyl-CoA Desaturase (SCD) | Metabolism |
A939572 是口服具有活性的硬脂酰 CoA 去饱和酶 1SCD1抑制剂,对mSCD1和hSCD1的IC50分别为 <4 nM 和 37 nM。 | |||
T14878 |
CAY10566
|
Dehydrogenase; Stearoyl-CoA Desaturase (SCD) | Metabolism |
CAY10566 是选择性的、口服具有活性的硬脂酰辅酶 A 去饱和酶 1 抑制剂,在小鼠和人酶测定中IC50分别为 4.5 和 26 nM。它具有显著的细胞活性,可阻断 HepG2 细胞中饱和长链脂肪酸-CoAs (LCFA-CoAs) 向单不饱和 LCFA-CoAs 的转化 。 | |||
T9722 |
YTX-465
|
Stearoyl-CoA Desaturase (SCD) | Metabolism |
YTX-465 是有效的硬脂酰辅酶 A 去饱和酶 (Ole1/SCD) 抑制剂,抑制 Ole1 和 SCD1的IC50=分别为 0.039 μM 和 30.4 μM。YTX-465在帕金森病和其他突触核蛋白病领域有研究的价值。 | |||
T7581 |
voxelotor
GBT 440 |
Others | Others |
Voxelotor (GBT 440) 是镰状血红蛋白 (HbS) 聚合抑制剂,有用于镰状细胞贫血病研究的潜力。 | |||
T1869 |
PluriSIn 1
4-吡啶羧酸 2-苯基酰肼,NSC 14613,PluriSIn #1,PluriSln 1 |
Apoptosis; Dehydrogenase; Stearoyl-CoA Desaturase (SCD) | Apoptosis; Metabolism |
PluriSIn 1 (NSC 14613) 是一种酰基-辅酶 A 去饱和酶抑制剂,是一种多能细胞特异性的抑制剂。 | |||
T12863 |
SCD1 inhibitor-1
|
Others | Others |
SCD1 inhibitor-1 is a potent and liver-selective inhibitor of stearoyl-CoA desaturase-1 (SCD1). | |||
T71175 |
SCD1 Inhibitor
|
||
SCD1 Inhibitor is a novel stearoyl-CoA desaturase1 (SCD1) inhibitor. | |||
T61841 |
SCD1-IN-1
|
||
SCD1-IN-1, a potent inhibitor of SCD1 (IC50: 5.8 nM), is valuable in dermatologic research [1]. | |||
T9003 |
CVT-11127
N-[2-[6-[[(3,4-二氯苯基)甲基]氨基]-2-(4-甲氧基苯基)-3-氧代-3,4-二氢吡啶并[2,3-B]吡嗪-4-基]乙基]乙酰胺 |
Dehydrogenase | Metabolism |
CVT-11127 是 SCD 抑制剂。它将细胞周期阻滞在 G1/S 期,诱导细胞凋亡。它可用于肺癌的研究。 | |||
T75396 | Sphingolipid ceramide N-deacylase (SCDase) | ||
Sphingolipid ceramide N-deacylase (SCDase) 催化糖鞘脂中的脂肪酸与鞘氨醇碱基间的N-酰基键断裂,进而生成溶血糖鞘脂。 | |||
T20950 |
MK-8245 analog
MK-8245-analog,MK 8245 analog |
Others | Others |
MK-8245 analog 是 MK-8245 的类似物,MK-8245 是一种肝脏靶向的硬脂酰辅酶 A 去饱和酶 (SCD) 抑制剂。它可用于治疗血脂异常和糖尿病。 | |||
T39520 |
Vamifeport
VIT-2763 |
Ferroptosis | Apoptosis |
Vamifeport (VIT-2763) 是一种新型具有口服活性且靶向铁转运蛋白的抑制剂,可降低 SCD Townes 模型中的溶血标志物。VIT-2763 可改善贫血和红细胞生成,可改善血管炎症,可研究 β-地中海贫血。 | |||
T13054 |
T-3764518
|
Dehydrogenase | Metabolism |
T-3764518 is a novel and potent inhibitor of stearoyl coenzyme A desaturase (SCD)(IC50 of 4.7 nM). | |||
T73188 |
RK-0133114
|
||
RK-0133114 是G9a 抑制剂,也是RK-701 的 R-对映体。RK-0133114 抑制 G9a 的IC50值为 3.7 μM。RK-0133114 可用于镰状细胞病 (SCD) 的研究。 | |||
T28892 |
SW208108
SW 208108,SW-208108 |
||
SW208108 is a tumor-specific irreversible inhibitor of stearoyl CoA desaturase (SCD). | |||
T64171 | LXR antagonist 2 | ||
LXR antagonist 2 (compound 10rr) 是一种有效的 LXR (肝 X 受体) 反向激动剂,能够作用于 LXRβ (IC50: 0.36 μM) 和 LXRα (IC50: 2.25 μM)。 LXR antagonist 2 是一种脂肪生成抑制剂,能够下调 LXR 靶基因 SREBP-1c、ACC、FAS 和 SCD-1。LXR antagonist 2 对 Triton WR-1339 诱导的高脂血症小鼠表现出降脂活性。 | |||
T81500 |
PF-07059013
|
||
PF-07059013是口服活性的镰状血红蛋白(HbS)非共价调制剂,具有纳摩尔级别的亲和力特异性结合Hb,展现出显著的红细胞(RBCs)分裂作用,适用于镰状细胞病(SCD)的研究。 | |||
T61975 |
Pociredir
|
||
Pociredir (FTX-6058) 是一种有效的、选择性的、具有口服活性的胚胎外胚层发育蛋白 (EED) 小分子抑制剂(KD= 0.163 nM)。Pociredir (FTX-6058) 在研究炎症或血红蛋白病中具有研究价值,如镰状细胞病 (SCD)。 | |||
T69671 | SR1903 TFA | ||
SR-1903 is a modulator of retinoic acid receptor-related orphan receptor γ (RORγ) and liver X receptor (LXR). It is an inverse agonist of RORγ and an agonist of LXR. It also binds to peroxisome proliferator-activated receptor γ (PPAR) but does not activate it. SR-1903 inhibits LPS-induced expression of triggering receptor expressed on myeloid cells 1 (TREM-1). It also inhibits LPS-induced expression of the LXR target genes IL-6 and IL-33 and increases expression of ABCG1, FASN, and SCD-1. SR-190... | |||
T38844 |
MK-8245 Trifluoroacetate
|
||
MK-8245 trifluoroacetate is a liver-targeting inhibitor of stearoyl-CoA desaturase (SCD) with IC50 of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1, with anti-diabetic and anti-dyslipidemic efficacy. IC50 value: 1 nM (hSCD1) Target: SCD1 in vitro: MK-8245, a phenoxy piperidine isoxazole derivative, has been identified as a potent and liver-specific SCD inhibitor. It contains a tetrazole acetic acid moiety, which is the key molecule for OATPs recognition and liver-targeting. MK... | |||
T35638 |
SR 1903
|
||
SR 1903 is a modulator of retinoic acid receptor-related orphan receptor γ (RORγ) and liver X receptor (LXR).1 It is an inverse agonist of RORγ (IC50 = ~100 nM in a cell-based reporter assay) and an agonist of LXR. It also binds to peroxisome proliferator-activated receptor γ (PPARγ; IC50 = 209 nM) but does not activate it. SR 1903 (10 μM) inhibits LPS-induced expression of triggering receptor expressed on myeloid cells 1 (TREM-1) in RAW 264.7 cells. It also inhibits LPS-induced expression of th... | |||
T36130 |
22(S)-hydroxy Cholesterol
22(S)-hydroxy Cholesterol,22β-hydroxy Cholesterol |
||
22(S)-hydroxy Cholesterol is a synthetic oxysterol and a modulator of the liver X receptor (LXR). [1] t prevents monocyte chemoattractant protein 1 (MCP-1) expression induced by the LXR agonist GW 3965 in primary hepatocytes and downregulates mRNA expression of the LXR target genes CD36, ACSL1, and SCD-1 in human myotubes. It decreases triacylglycerol and diacylglycerol synthesis from labeled palmitate and acetate, respectively, in human myoblasts by 50% when used at a concentration of 10 uM. 22... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3341 |
Elemicin
Elemicine,3,4,5-trimethoxyallylbenzene,榄香素 |
Influenza Virus; 5-HT Receptor; Stearoyl-CoA Desaturase (SCD) | GPCR/G Protein; Metabolism; Microbiology/Virology; Neuroscience |
Elemicin (Elemicine) 是广泛分布于许多草药和香料中的一种烯基苯。它是芳香族食品中的主要成分之一,具有抗微生物,抗氧化剂和抗病毒活性,有遗传毒性和致癌性。它通过代谢激活抑制硬脂酰辅酶 A 去饱和酶 1。 |